• Home  /
  • Research & Analysis   /
  • Two Volume Gainers: Lloyds Banking Group plc (NYSE:LYG), AstraZeneca PLC (NYSE:AZN)

Two Volume Gainers: Lloyds Banking Group plc (NYSE:LYG), AstraZeneca PLC (NYSE:AZN)

Lloyds Banking Group plc (NYSE:LYG)

The shares of Lloyds Banking Group plc (NYSE:LYG) started off the last trading session with the price of $3.81 while closing the day with the price of $3.74. The shares of Lloyds Banking Group plc (NYSE:LYG) Fell -2.86% with the Loss of -0.07 points.

The shares of Lloyds Banking Group plc (NYSE:LYG) traded with the day volume of 3.69 Million shares whereas its average trading volume is 5 Million.

While analyzing the past performance of the stock we can see that the shares of Lloyds Banking Group plc (NYSE:LYG) Loss -0.8% in the last week while Falling -5.32% in the last month. Past quarter performance shows the green light with 2.47%. The semi-annual and annual performance shows 4.76% and 9.58% respectively.

Some critical values of the shares of Lloyds Banking Group plc (NYSE:LYG) to be discussed here are: the beta which shows the value at 0.9 while Average True Range of Lloyds Banking Group plc (NYSE:LYG) demonstrate the value at 0.06. The weekly and monthly volatility of the shares of Lloyds Banking Group plc (NYSE:LYG) are indicated at 1.35% and 1.31%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 35.26.

While studying the financial position of the shares of Lloyds Banking Group plc (NYSE:LYG), we can see that the Market capitalization of the company is at 67.31 Billion. The shares outstanding for the company is 18 Billion and the shares float stands at 17.97 Billion. The income of the company stand at 4.38 Billion while the sales stand at 22.31 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.24, Price to Earnings or P/E is at 15.45, Price to Sales P/S show the value of 3.02, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at 0.061.


AstraZeneca PLC (NYSE:AZN)

AstraZeneca PLC (NYSE:AZN) started its previous trading session at $34.43 and closed at $34.47 showing a Fell of -0.4 Percent.

The Company traded with an average Volume of 3.98 Million whereas, its Day Volume stood at 3.68 Million.

Looking at the performance of the stock, AstraZeneca PLC (NYSE:AZN) Gain 1.92% in the last week in its shares price and 1.89% in the last month. Quarterly performance shows a green of 3.98 Percent while Semi-Annual and Annual performances shows a 4.68 and 11.27 percent respectively.

Beta for AstraZeneca PLC (NYSE:AZN) stands at 0.68 while the ATR (average true range) is at 0.46. The Stock’s Weekly and Monthly Volatility is 1.12% and 1.21% respectively showing a RSI value of 52.49.

While studying the financial position of the shares of AstraZeneca PLC (NYSE:AZN), we can see that the Market capitalization of the company is at 87.28 Billion. The shares outstanding for the company is 2.53 Billion and the shares float stands at 2.53 Billion.

The Company generated an income of 2.97 Billion and the sales of 22.47 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $1.17 a share. P/E (price to earnings) and P/S (price to sales) values are 29.44 and 3.89 respectively.

The Return on Assets stands at 0.047, ROE shows a value of 0.217 and ROI for AstraZeneca PLC (NYSE:AZN) is 0.131 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment